Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

A brief history of hepatitis milestones.

Trepo C.

Liver Int. 2014 Feb;34 Suppl 1:29-37. doi: 10.1111/liv.12409. Review.

PMID:
24373076
2.

Towards the eradication of hepatitis B in Taiwan.

Wait S, Chen DS.

Kaohsiung J Med Sci. 2012 Jan;28(1):1-9. doi: 10.1016/j.kjms.2011.10.027. Epub 2011 Dec 16. Review.

3.

China's efforts to shed its title of "Leader in liver disease".

Li X, Xu WF.

Drug Discov Ther. 2007 Oct;1(2):84-5.

4.

Therapy of viral hepatitis.

Hoofnagle JH.

Digestion. 1998 Aug;59(5):563-78. Review.

PMID:
9705540
5.

Prevention of hepatocellular carcinoma in hepatitis B virus infection.

Lim SG, Mohammed R, Yuen MF, Kao JH.

J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x. Review.

PMID:
19702903
6.

Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?

Lok AS.

J Gastroenterol Hepatol. 2011 Feb;26(2):221-7. doi: 10.1111/j.1440-1746.2010.06576.x.

PMID:
21070361
7.

Viral hepatitis.

Trépo C, Zoulim F, Pradat P.

Curr Opin Infect Dis. 1999 Oct;12(5):481-90.

PMID:
17035815
8.

The impact of human immunodeficiency virus on viral hepatitis.

Mallet V, Vallet-Pichard A, Pol S.

Liver Int. 2011 Jan;31 Suppl 1:135-9. doi: 10.1111/j.1478-3231.2010.02394.x. Review.

PMID:
21205151
9.

Hepatitis B vaccines: protective efficacy and therapeutic potential.

Michel ML, Tiollais P.

Pathol Biol (Paris). 2010 Aug;58(4):288-95. doi: 10.1016/j.patbio.2010.01.006. Epub 2010 Apr 10. Review.

PMID:
20382485
10.

Global control of hepatitis B virus infection.

Kao JH, Chen DS.

Lancet Infect Dis. 2002 Jul;2(7):395-403. Review.

PMID:
12127351
11.

Surveillance for acute viral hepatitis - United States, 2007.

Daniels D, Grytdal S, Wasley A; Centers for Disease Control and Prevention (CDC)..

MMWR Surveill Summ. 2009 May 22;58(3):1-27.

12.

[Monitoring patients with chronic hepatitis during and after therapy].

Colić-Cvrlje V, Mise S.

Acta Med Croatica. 2009 Dec;63(5):377-83. Croatian.

PMID:
20198895
13.

Hepatitis B virus and the control of hepatocellular carcinoma.

Blumberg BS.

IARC Sci Publ. 1984;(63):243-61.

PMID:
6100273
14.

Hepatitis B virus: from diagnosis to treatment.

Dény P, Zoulim F.

Pathol Biol (Paris). 2010 Aug;58(4):245-53. doi: 10.1016/j.patbio.2010.05.002. Epub 2010 Jul 1. Review.

PMID:
20580167
15.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
16.

Pathogenesis, diagnosis and management of hepatitis C.

Boyer N, Marcellin P.

J Hepatol. 2000;32(1 Suppl):98-112. Review.

PMID:
10728798
17.

A virological perspective on the need for vaccination.

Locarnini S.

J Viral Hepat. 2000 May;7 Suppl 1:5-6. Review.

PMID:
10866836
18.

Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.

Chen DS.

Princess Takamatsu Symp. 1995;25:27-32. Review.

PMID:
8875606
19.

Hepatocellular carcinoma in Taiwan.

Chen DS.

Hepatol Res. 2007 Sep;37 Suppl 2:S101-5.

PMID:
17877468
20.

Viral hepatitis: global goals for vaccination.

Lavanchy D.

J Clin Virol. 2012 Dec;55(4):296-302. doi: 10.1016/j.jcv.2012.08.022. Epub 2012 Sep 21. Review.

PMID:
22999800

Supplemental Content

Support Center